Onera Health
Private Company
Total funding raised: $39M
Overview
Onera Health is a commercial-stage medical technology company focused on transforming sleep diagnostics. Its core product, the Onera Sleep Test System (STS), is a self-applied, wireless patch system that captures the full set of signals required for gold-standard polysomnography (PSG) at home or in a clinic. The company operates a PSG-as-a-service model, combining its FDA-cleared and CE-marked hardware with a cloud-based platform for data analysis and reporting. Onera targets the large and underserved market of sleep disorder diagnostics, offering a solution that improves patient comfort, accessibility, and clinical workflow efficiency.
Technology Platform
The Onera Sleep Test System (STS) is a patch-based, no-wire sensor system that captures the full polysomnography (PSG) signal set (EEG, EOG, EMG, ECG, respiratory effort, airflow, SpO2, position). It is paired with a cloud-based Digital Health Platform for data management, analysis, and reporting, enabling PSG studies to be conducted at home or in-clinic with minimal setup.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Onera competes in the sleep diagnostics market against traditional in-lab PSG providers and companies offering simpler Type III home sleep apnea tests (HSAT) like ResMed and Philips. Its primary differentiation is offering a full, no-wire PSG for use at home. It also faces potential long-term competition from advanced consumer wearables, though these lack clinical validation for diagnostic use.